R&D in the pharmaceutical industry and the US investment in innovation

被引：0

作者：

Wollowitz, S ^{[1
]}

Kermani, F ^{[1
]}

机构：

[1] Wollowitz Associates LLC, Moraga, CA 94556 USA

来源：

ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY | 2005年 / 229卷

关键词：

D O I：

暂无

中图分类号：

O6 [化学];

学科分类号：

0703 ;

摘要：

009-BMGT

引用

页码：U251 / U251

页数：1

共 50 条

[31] Brokering innovation to better leverage R&D investment
Kraatz, Judy A.
Hampson, Keith D.
[J]. BUILDING RESEARCH AND INFORMATION, 2013, 41 (02): : 187 - 197
[32] Zhejiang Enterprises' R&D Management Innovation-The Investigation of Oversea R&D Investment
Zhu Qin
[J]. PROCEEDINGS OF 2009 INTERNATIONAL CONFERENCE ON GROWTH OF FIRM AND MANAGEMENT INNOVATION, 2009, : 405 - 409
[33] R&D spending report for US industry
不详
[J]. POWDER METALLURGY, 1998, 41 (03) : 148 - 149
[34] Cavity production and R&D in Us industry
Rathke, J.
[J]. 2007 IEEE PARTICLE ACCELERATOR CONFERENCE, VOLS 1-11, 2007, : 1349 - 1349
[35] City to industry:: talk R&D to us
不详
[J]. CHEMISTRY IN BRITAIN, 1998, 34 (12) : 10 - 10
[36] Pharmaceutical industry R&D alliance: compulsions and challenges
Pandey, M
Chaturvedi, M
[J]. CHIMICA OGGI-CHEMISTRY TODAY, 2005, 23 (01) : 28 - 30
[37] Market structure, R&D and advertising in the pharmaceutical industry
Matraves, C
[J]. JOURNAL OF INDUSTRIAL ECONOMICS, 1999, 47 (02): : 169 - 194
[38] Virtual R&D organisations: Lessons for the pharmaceutical industry
Chiesa, V
Manzini, R
[J]. INNOVATION IN TECHNOLOGY MANAGEMENT - THE KEY TO GLOBAL LEADERSHIP: THE KEY TO GLOBAL LEADERSHIP, 1997, : 520 - 523
[39] The outsourcing of R&D through acquisitions in the pharmaceutical industry
Higgins, Matthew J.
Rodriguez, Daniel
[J]. JOURNAL OF FINANCIAL ECONOMICS, 2006, 80 (02) : 351 - 383
[40] Key issues in the pharmaceutical industry: consequences on R&D
Malik, Nafees N.
[J]. EXPERT OPINION ON DRUG DISCOVERY, 2009, 4 (01) : 15 - 19

← 1 2 3 4 5 →